[1] Fearnley J M, Lees A J. Ageing and Parkinson's disease: substantia nigra regional selectivity [J]. Brain,1991, 114 (Pt 5): 2283-2301. [2] Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease [J]. Nat Genet,1998, 18(2): 106-108. [3] Polymeropoulos M H, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [J]. Science,1997, 276(5321): 2045-2047. [4] Li W W, Yang R, Guo J C, et al. Localization of alpha-synuclein to mitochondria within midbrain of mice [J]. Neuroreport, 2007, 18(15): 1543-1546. [5] Spillantini M G, Schmidt M L, Lee V M, et al. Alpha-synuclein in Lewy bodies [J]. Nature,1997, 388(6645): 839-840. [6] Feany M B. Studying human neurodegenerative diseases in flies and worms [J]. J Neuropathol Exp Neurol, 2000, 59(10): 847-856. [7] Lo B C, Ridet J L, Schneider B L, et al. alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease [J]. Proc Natl Acad Sci U S A, 2002, 99(16): 10813-10818. [8] Shen J, Du T, Wang X, et al. alpha-Synuclein amino terminus regulates mitochondrial membrane permeability [J]. Brain Res, 2014, 1591: 14-26. [9] Arima K, Ueda K, Sunohara N, et al. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy [J]. Acta Neuropathol, 1998, 96(5): 439-444. [10] Hsu L J, Sagara Y, Arroyo A, et al. alpha-synuclein promotes mitochondrial deficit and oxidative stress [J]. Am J Pathol, 2000, 157(2): 401-410. [11] Simon D K,Lin M T, Zheng L, et al. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease [J]. Neurobiol Aging, 2004, 25(1): 71-81. [12] Tanner C M, Ottman R, Goldman S M, et al. Parkinson disease in twins: an etiologic study [J]. JAMA, 1999, 281(4): 341-346. [13] Sakka N, Sawada H, Izumi Y, et al. Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone [J]. Neuroreport,2003, 14(18): 2425-2428. [14] Zhang J, Montine T J, Smith M A, et al. The mitochondrial common deletion in Parkinson's disease and related movement disorders [J]. Parkinsonism Relat Disord,2002, 8(3): 165-170. [15] Subramaniam S R, Vergnes L, Franich NR, et al. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein [J]. Neurobiol Dis, 2014, 70: 204-213. [16] Shimura-Miura H, Hattori N, Kang D, et al. Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease [J]. Ann Neurol,1999, 46(6): 920-924. [17] Terland O, Flatmark T, Tangeras A, et al. Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species [J]. J Mol Cell Cardiol,1997, 29(6): 1731-1738. [18] Hastings T G, Lewis D A, Zigmond M J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections [J]. Proc Natl Acad Sci U S A,1996, 93(5): 1956-1961. [19] 付越姣,段春礼, 龚普盛, 等. PINK1与α-synuclein相互作用结构域鉴定 [J]. 中国生物工程杂志,2011(12): 10-14. [20] 范春香, 崔韬, 谷利, 等. 帕金森病相关蛋白PINK1和α-突触核蛋白相互作用研究 [J]. 中国生物工程杂志,2008(12): 7-11. [21] Sarafian T A, Ryan C M, Souda P, et al. Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human alpha-synuclein [J]. PLoS One,2013, 8(5): e63557. [22] Dias V, Junn E, Mouradian M M. The role of oxidative stress in Parkinson's disease [J]. J Parkinsons Dis, 2013, 3(4): 461-491. [23] Banerjee K, Munshi S, Sen O, et al. Dopamine cytotoxicity involves both oxidative and nonoxidative pathways in SH-SY5Y cells: potential role of alpha-synuclein overexpression and proteasomal inhibition in the etiopathogenesis of parkinson's disease [J]. Parkinsons Dis,2014, 2014: 878935. [24] Beinlich F R, Drees C, Piehler J, et al. Shuttling of PINK1 between mitochondrial microcompartments resolved by triple-color superresolution microscopy [J]. Acs Chem Biol,2015, 10(9): 1970-1976. [25] Han J Y, Kim J S, Son JH. Mitochondrial homeostasis molecules: regulation by a trio of recessive Parkinson's disease genes [J]. Exp Neurobiol,2014, 23(4): 345-351. [26] Morais V A, Haddad D, Craessaerts K, et al. PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling [J]. Science,2014, 344(6180): 203-207. |